Erasca (ERAS) Enterprise Value

Price: $1.26
Market Cap: $356.92M
Avg Volume: 1.50M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.222
52W Range: $1.04-3.45
Website: Erasca
Enterprise Value Summary (Quarterly)

According to Erasca's latest quarterly financial reports:

  • The enterprise value (EV) is 5.85B, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
  • The market capitalization is 5.87B, which is calculated by multiplying the current share price by the total number of outstanding shares.
  • The stock price is $2.51, with 2.34B shares outstanding.
  • The company has 67.74M in cash and cash equivalents and 51.89M in total debt.

Enterprise Value (EV) Formula:

EV = Market Cap + Total Debt - Cash and Cash Equivalents

Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.

Enterprise Value

$5.85B

Market Cap

$5.87B

Total Debt

$51.89M

Cash and Equivalents

$67.74M

Historical Enterprise Value
$20.00B$20.00B$16.00B$16.00B$12.00B$12.00B$8.00B$8.00B$4.00B$4.00B$0.00$0.00Enterprise ValueJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '24
Erasca Historical Enterprise Values

The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.

Date Enterprise Value EV Change (%) Stock Price Number of Shares Market Cap Cash & Equivalents Total Debt
December 31, 2024 $5.85B -4.85% $2.51 2.34B $5.87B $67.74M $51.89M
September 30, 2024 $6.15B 48.84% $2.73 2.26B $6.17B $68.89M $52.94M
June 30, 2024 $4.13B 59.12% $2.44 1.74B $4.25B $172.80M $53.97M
March 31, 2024 $2.60B 2.60% $2.16 1.21B $2.61B $76.73M $61.84M
December 31, 2023 $2.53B 9.34% $2.13 1.21B $2.57B $93.08M $55.86M
September 30, 2023 $2.31B -28.37% $1.97 1.20B $2.37B $112.86M $56.76M
June 30, 2023 $3.23B -4.54% $2.76 1.20B $3.31B $138.79M $57.64M
March 31, 2023 $3.39B -18.79% $3.01 1.20B $3.60B $272.76M $58.05M
December 31, 2022 $4.17B -43.46% $4.31 1.02B $4.40B $284.22M $55.10M
September 30, 2022 $7.37B 44.98% $7.8 966.39M $7.54B $219.26M $54.46M
June 30, 2022 $5.09B -35.77% $5.57 961.55M $5.36B $298.01M $27.64M
March 31, 2022 $7.92B -45.28% $8.6 955.93M $8.22B $333.35M $29.43M
December 31, 2021 $14.47B -11.79% $15.58 950.62M $14.81B $360.49M $18.79M
September 30, 2021 $16.40B 424.12% $21.22 793.02M $16.83B $445.81M $20.23M
June 30, 2021 $3.13B 0.43% $17.43 188.37M $3.28B $156.40M $2.56M
March 31, 2021 $3.12B -0.44% $17.43 188.37M $3.28B $169.99M $2.77M
December 31, 2020 $3.13B -4.67% $17.43 183.15M $3.19B $65.38M $2.99M
September 30, 2020 $3.28B 0.00% $17.43 188.37M $3.28B $- $-
June 30, 2020 $3.28B -74.14% $17.43 188.37M $3.28B $- $-
March 31, 2020 $12.70B - $17.43 725.55M $12.65B $-50.37M $-

Related Metrics

Explore detailed financial metrics and analysis for ERAS.